Michael Esther

    • Michael EstherMichael Esther
      ·08-21 06:23

      The 5-Step Strategy Built for a Bull Market

      If you're bullish on the market and want a strategy that focuses more on time in the market than constant trading, this framework is worth studying. It’s built around a simple idea: use long-dated options for upside exposure, gradually shift profits into broad-market assets, and eventually let compounding do more of the work. ① Start With LEAPS 🚀 Focus on strong, large-cap names with long-term growth potential, such as: $Tesla Motors(TSLA)$ $NVIDIA(NVDA)$ $Apple(AAPL)$ $Amazon.com(AMZN)$ $Meta Platforms, Inc.(META)$ $Alphabet(GOOG)$ Ins
      1.07KComment
      Report
      The 5-Step Strategy Built for a Bull Market
    • Michael EstherMichael Esther
      ·08-20

      4 SPY Stocks Down 40%-60%, But EPS Keeps Rising

      These 4 stocks are down 40%-60% from its highs. But, EPS keeps going up every quarter for each of them too. Here's the 4 most undervalued stocks in $SPDR S&P 500 ETF Trust(SPY)$ : 1st stock is: $Fair Isaac(FICO)$ its down almost 40% right now. It has never printed a loss quarter and eps keeps accelerating. Honestly, it shouldn't even be down this year. It actually makes no sense to me. $FICO -Fiscal Q3 revenue $674M, up 26%. -GAAP EPS $10.45, up 41%. Non GAAP $12.18, up 42%. -$370M of free cash flow in a single quarter. -Platform ARR up 62% to $413M, now bigger than legacy for the first time. -Repurchased $1.96B of stock in the quarter. Yes, its very expensive this stock. So here's 3 more that are chea
      576Comment
      Report
      4 SPY Stocks Down 40%-60%, But EPS Keeps Rising
    • Michael EstherMichael Esther
      ·08-20

      Cancer Vaccine Phase 3: 5 Biotechs On the Brink

      $Moderna, Inc.(MRNA)$ just showed how explosive a successful cancer-vaccine catalyst can be. A $1,000 overnight options bet reportedly turned into more than $7.3M after Moderna announced a major Phase 3 win for its personalized cancer vaccine program. But here's the catch: This is an extremely high-risk game. Two cancer-vaccine Phase 3 programs have already failed in 2026, including $IOBT, which filed for Chapter 7 after missing its primary endpoint, and $IMMP, which discontinued its Phase 3 program for futility. So the next wave of catalysts could create massive winners — or wipe out years of work. Here are 5 biotech names with major clinical readouts ahead: 1. $CG Oncology Inc.(CGON)$ Oncolytic virus de
      2.50K1
      Report
      Cancer Vaccine Phase 3: 5 Biotechs On the Brink
    • Michael EstherMichael Esther
      ·08-18

      💰 12 Stocks Institutions Are Buying on the Dip

      12 stocks large institutions are buying back at cheap prices. No one is even paying attention to these right now: I'd add 2-3 of these stocks right now! Which ones are you interested in the most? 1. $PayPal(PYPL)$ down ~80% Stripe and Advent bidding at 12x earnings, Venmo barely monetized. 2. $Nike(NKE)$ down ~75% Iconic brand at 52-week lows, turnaround priced as permanent decline. 3. $Uber(UBER)$ down ~22% 15x earnings, $10B free cash flow, robotaxis scaling to 15 cities. 4. $Lululemon Athletica(LULU)$ down ~77% Under 10x earnings, no debt, China growing while sentiment bottoms. 5.
      4.95K2
      Report
      💰 12 Stocks Institutions Are Buying on the Dip
    • Michael EstherMichael Esther
      ·08-18

      Why Rising Yields Could Crush Stocks

      When yields spike fast, $SPDR S&P 500 ETF Trust(SPY)$ can crash 20% in 1 day. 6 things are pushing yields up at once. In plain terms: 1. Inflation won't fully die. University of Michigan year ahead inflation expectations rose again in August, a 5th straight month above 4%. Not good when prices are rising! 2. The government is borrowing way more than expected. The CBO just raised its deficit estimate to $2.1 trillion, $200 billion above February's figure. Total federal debt is near $39.8 trillion, and the annual interest bill now exceeds what Washington spends on Medicare or the military. 3. Oil. The Iran-Oman talks over the Strait of Hormuz have traders watching energy prices, and expensive oil feeds straight into inflation. 4. Nobody knows wha
      485Comment
      Report
      Why Rising Yields Could Crush Stocks
    • Michael EstherMichael Esther
      ·08-17

      Entry Strategy: 5-Step Confirmation

      A good entry is not about chasing price after a move has already started. The goal is to wait for price to reach an important level, confirm that buyers are stepping in, and then enter with clearly defined risk. This five-step process keeps the setup simple and gives you a structured way to approach short-term trades on the 1-minute chart. 1. Wait for the Setup The first step is to identify a meaningful support or demand zone. Wait for price to pull back into that area rather than entering while price is extended. The level should be one you have already identified before the trade begins. 2. Watch the Reaction Once price reaches support, look for evidence that sellers are losing control. A bullish rejection candle with a long lower wick or a strong close can show that buyers are defending
      291Comment
      Report
      Entry Strategy: 5-Step Confirmation
    • Michael EstherMichael Esther
      ·08-15

      Could $NLST Be the Next $NVDA? 👀

      I haven’t seen a setup like this since $NVIDIA(NVDA)$ was trading under $20. Here is the set-up: $Netlist, Inc.(NLST)$ just signed a 5 year alliance with $Samsung Electronics Co., Ltd.(SSNLF)$ . Patent cross license. Up to $750M in license fees. $1.5B in memory supply. On a $1.7B market cap. Then two days ago they filed a fresh ITC action against $Micron Technology(MU)$ $SUPER MICRO COMPUTER INC(SMCI)$ $Hewlett Packard Enterprise(HPE)$ and Lenovo. $MU is the last holdout. There's already a $445M willful infringement verdict sitting there
      3.64K1
      Report
      Could $NLST Be the Next $NVDA? 👀
    • Michael EstherMichael Esther
      ·08-14

      $NBIS $BE $SPCX Would Be The Next 1000% Winners

      I'm known to pick 1000% winners: $IONQ Inc.(IONQ)$ at $5$AST SpaceMobile, Inc.(ASTS)$ at $2$Palantir Technologies Inc.(PLTR)$ at $17$NVIDIA(NVDA)$ at $18 in February 2023 Right now, three names stand out to me: 1. $NEBIUS(NBIS)$ Revenue is up 454%, with 5GW of power contracted and a $37B signed backlog. Buy zone: $170–$180 The post-earnings gap could fill, with the old $220 resistance potentially turning into support. 2. $Bloom Energy Corp(BE)$ AI data centers need power before they need more GPUs. Buy zone: $170–$180 The stock broke
      2.18KComment
      Report
      $NBIS $BE $SPCX Would Be The Next 1000% Winners
    • Michael EstherMichael Esther
      ·08-13

      With $2,000 or Less, Here’s How I Rank AI Stocks

      If you have $2,000 or less, you don't need to own everything. The key is to focus on the strongest names within each part of the AI and technology ecosystem and prioritize quality over quantity. Here’s how I would rank them from strongest to weaker within each category: ☁️ Neoclouds $NEBIUS(NBIS)$ > $CoreWeave, Inc.(CRWV)$ > $Cipher Mining Inc.(CIFR)$ > $IREN Ltd(IREN)$ 🧠 Chips $Advanced Micro Devices(AMD)$ > $NVIDIA(NVDA)$ > $Broadcom(AVGO)$ 🏭 Foundries
      7.25KComment
      Report
      With $2,000 or Less, Here’s How I Rank AI Stocks
    • Michael EstherMichael Esther
      ·08-13

      How I Turned $500 Into $1M+

      Exactly a few years ago around this time, I turned less than $500 into $1,000,000+ You can learn my best strategy in less than 5 min: 1. This strategy only works if we are in a bull market or a trending up market. - I think we are right now. - The stock market is led by strong tech companies. - The economy is it low employment and inflation is slowly coming down. - $SPDR S&P 500 ETF Trust(SPY)$ end of year targets are at $800 now with $900 by 2027 2. You will need $1000-$2000 to start the account. - Buy 1 or 2 contracts at a time but do not go in heavy. - You do not need to go in heavy this will only increase your chance of losing all your money. - The options are swing trades similar to my $Microsoft(MSFT
      2.21KComment
      Report
      How I Turned $500 Into $1M+
     
     
     
     

    Most Discussed